APA

Schennach-Wolff R., Möller H., Jäger M., Seemüller F., Obermeier M., Messer T., Laux G., Pfeiffer H., Naber D., Schmidt L. G., Gaebel W., Klosterkötter J., Heuser I., Maier W., Lemke M. R., Rüther E., Klingberg S., Gastpar M. & Riedel M. (20110502). A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials. : Pharmacopsychiatry.

Chicago

Schennach-Wolff R, Möller H-J, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt L G, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke M R, Rüther E, Klingberg S, Gastpar M and Riedel M. 20110502. A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials. : Pharmacopsychiatry.

Harvard

Schennach-Wolff R., Möller H., Jäger M., Seemüller F., Obermeier M., Messer T., Laux G., Pfeiffer H., Naber D., Schmidt L. G., Gaebel W., Klosterkötter J., Heuser I., Maier W., Lemke M. R., Rüther E., Klingberg S., Gastpar M. and Riedel M. (20110502). A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials. : Pharmacopsychiatry.

MLA

Schennach-Wolff R, Möller H-J, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt L G, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke M R, Rüther E, Klingberg S, Gastpar M and Riedel M. A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials. : Pharmacopsychiatry. 20110502.